Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 361 AL 375

Plant-derived bioactive compounds modulate the gut microbiota in Alzheimer's disease: Metabolite signaling, neuroimmune circuits, and systems-level regulation

Xue D, Hu X, Li R, Sun T, Qian S, Chu F, Gao H, Li F, Cai B.

Phytomedicine. 2026 Apr;153:157919. doi: 10.1016/j.phymed.2026.157919. Epub 2026 Feb 3.

Beyond the streetlight: a TREAT-AD perspective on where to find new Alzheimer's targets

Cary GA, Wiley JC, Carter GW, Levey AI.

Alzheimers Dement. 2026 Feb;22(2):e71142. doi: 10.1002/alz.71142.

Lithium and the Brain-Bone Axis: A Bridge between Osteoporosis and Alzheimer's Disease

Lee JW, Hasegawa T, Ikedo A, Mizuno K, Amizuka N, Kong SW.

Curr Osteoporos Rep. 2026 Feb 10;24(1):7. doi: 10.1007/s11914-026-00954-5.

The application of exosomes derived by mesenchymal stem cell from different tissues in the management of Alzheimer's disease

Gao C, Li Y, Zhou B, Liu Y, Hao MQ, Sun H, Jin Z, Li LL, Yang XF, Guo XL, Yin Y.

Nanomedicine (Lond). 2026 Mar;21(6):839-851. doi: 10.1080/17435889.2026.2629030. Epub 2026 Feb 10.

Alzheimer's disease: Current therapeutic strategies and emerging perspectives for multifactorial intervention

de Melo Silva JG, de Medeiros Barros W, Lopes NMCP, Bellozi PMQ.

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Mar 20;145:111640. doi: 10.1016/j.pnpbp.2026.111640. Epub 2026 Feb 10.

Targeting Alzheimer's pathophysiology with carbon dots: from mechanisms to therapy

Tripathi S, Singh R, Jaiswal S, Sethi M, Rana R, Mishra K, Chourasia MK.

J Mater Chem B. 2026 Jan 14;14(2):389-422. doi: 10.1039/d5tb02134k.

NLRP3 inflammasome and Alzheimer's disease: bridging inflammation and neurodegeneration

Wasim R, Azmi S, Ahmad A, Srivastava A.

Inflammopharmacology. 2026 Feb;34(2):951-966. doi: 10.1007/s10787-025-02092-3. Epub 2026 Jan 5.

Synergistic potential of TREM2 agonists and exercise training in Alzheimer's disease

Zhang J, St Pierre Schneider B, Muguerza E, Chung E, Hsu CG.

Am J Physiol Endocrinol Metab. 2026 Mar 1;330(3):E298-E308. doi: 10.1152/ajpendo.00124.2025. Epub 2026 Jan 6.

Engineering nanobodies for drug delivery systems in Alzheimer's disease

Jootar T, Hongeng S, Chiangjong W.

Artif Cells Nanomed Biotechnol. 2026 Dec;54(1):104-118. doi: 10.1080/21691401.2026.2617707. Epub 2026 Jan 22.

Smart Biosensing Nanomaterials for Alzheimer's Disease: Advances in Design and Drug Delivery Strategies to Overcome the Blood-Brain Barrier

Rajkumar M, Tian F, Javed B, Prajapati BG, Deepak P, Girigoswami K, Karmegam N.

Biosensors (Basel). 2026 Jan 21;16(1):66. doi: 10.3390/bios16010066.

Targeting the Gut Microbiota: Mechanistic Investigation of Polyphenol Modulation of the Gut-Brain Axis in Alzheimer's Disease

Wang Z, Ba S, Li M, Wei Y, Wang Y, Mao J, Xiang Y, Qin D, Zeng C.

Int J Mol Sci. 2026 Jan 7;27(2):604. doi: 10.3390/ijms27020604.

Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies

Upadhayay S.

Int Immunopharmacol. 2026 Mar 15;173:116285. doi: 10.1016/j.intimp.2026.116285. Epub 2026 Jan 29.

Alzheimer's Disease: Evolving Therapeutics, Scientific Progress, and Key Challenges

K SY, Goswami AK, Prasad MR, Chauhan VS, Yadav N.

J Med Chem. 2026 Feb 26;69(4):3693-3718. doi: 10.1021/acs.jmedchem.5c02468. Epub 2026 Feb 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias